Vaccinex Stock (NASDAQ: VCNX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 13.212K |
Day Range | - - - |
52 Wk Range | 4.432 - 100.800 |
Market Cap | $9.823M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 1.96% |
Days to Cover | 1.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vaccinex (NASDAQ: VCNX) through any online brokerage.
Other companies in Vaccinex’s space includes: Virios Therapeutics (NASDAQ:VIRI), Addex Therapeutics (NASDAQ:ADXN), BioRestorative Therapies (NASDAQ:BRTX), NuCana (NASDAQ:NCNA) and Galera Therapeutics (NASDAQ:GRTX).
The latest price target for Vaccinex (NASDAQ: VCNX) was reported by Oppenheimer on Friday, September 25, 2020. The analyst firm set a price target for 7.00 expecting VCNX to rise to within 12 months (a possible 12.90% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Vaccinex (NASDAQ: VCNX) is $6.2 last updated May 10, 2024 at 4:31 PM EDT.
There are no upcoming dividends for Vaccinex.
Vaccinex’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Vaccinex.
Vaccinex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.